Discontinued — last reported Q1 '22
An increase suggests rising long-term debt or deferred obligations within the segment, potentially indicating higher future cash outflows or structural liabilities, while a decrease suggests deleveraging or the settlement of long-term commitments.
This metric represents the total long-term financial obligations and liabilities attributed to the 'Other' business segm...
Peer companies in pharmaceutical distribution often report similar 'Corporate' or 'Other' segment liabilities, though the composition varies based on how they allocate pension, environmental, or litigation-related long-term accruals.
mck_segment_other_segments_noncurrent_liability| Q1 '22 | |
|---|---|
| Value | $0.00 |